NGeneBio Co., Ltd. Logo

NGeneBio Co., Ltd.

Develops NGS-based molecular diagnostic products and software for oncology.

354200 | KO

Overview

Corporate Details

ISIN(s):
KR7354200008
LEI:
Country:
South Korea
Address:
서울특별시 구로구 디지털로 288 303호. 304호. 305호. 306호. 307호. 제지1층 제비 127호, 제지1층 제비 1, 구로구

Description

NGeneBio Co., Ltd. is a precision diagnostics company specializing in Next-Generation Sequencing (NGS) technology. The company develops and commercializes molecular diagnostic products, including in-vitro diagnostic (IVD) and companion diagnostic (CDx) solutions. Its primary focus is on oncology, offering NGS panels for the analysis of solid tumors and hematologic malignancies. Complementing its diagnostic assays, NGeneBio provides integrated bioinformatics software for comprehensive data analysis and interpretation. The company's portfolio also includes liquid biopsy technologies and personal genetic testing services, all aimed at providing precise genomic information to guide clinical decision-making.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-27 00:00
[기재정정]최대주주변경을수반하는주식양수도계약체결
Korean 23.7 KB
2025-05-23 00:00
주식등의대량보유상황보고서(일반)
Korean 97.5 KB
2025-05-16 00:00
최대주주변경을수반하는주식양수도계약체결
Korean 24.1 KB
2025-05-16 00:00
주주총회소집결의 (임시주주총회)
Korean 6.3 KB
2025-05-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-05-16 00:00
투자판단관련주요경영사항 (경영지배인 선임)
Korean 6.8 KB
2025-05-16 00:00
주요사항보고서(유상증자결정)
Korean 48.4 KB
2025-05-16 00:00
[기재정정]최대주주변경을수반하는주식양수도계약체결
Korean 27.2 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 2.0 MB
2025-04-25 00:00
전환가액의조정
Korean 11.2 KB
2025-03-31 00:00
정기주주총회결과
Korean 25.9 KB
2025-03-31 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 13.0 KB
2025-03-31 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 20.9 KB
2025-03-31 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 25.8 KB
2025-03-31 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 27.8 KB

Automate Your Workflow. Get a real-time feed of all NGeneBio Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NGeneBio Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NGeneBio Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.